You just read:

Diazon Pharmaceuticals' anti-cancer agent DZ-2384 mechanism for high activity and low neurotoxicity published by McGill researchers in Science Translational Medicine

News provided by

Diazon Pharmaceuticals Inc.

Nov 16, 2016, 16:24 ET